Cri Worldwide, Llc

Philadelphia, Pennsylvania 19149

0 studies enrolling now · 28 studies all time

What they study most

ADHD, Alzheimer's Disease, Attention Deficit Hyperactivity Disorder, Attention-Deficit/Hyperactivity Disorder, Attention-deficit/Hyperactivity Disorder, Autism, Bipolar Depression, Chronic Hepatitis C Virus, Chronic Low Back Pain, Chronic Nonmalignant and Nonneuropathic Pain, Chronic Pain, Depression

Studies at this site

• Long-Term Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Pain — Completed
• A Study of Tanezumab in Adults With Chronic Low Back Pain — Completed
• SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study — Stopped early
• SPD503 (Guanfacine Hydrochloride) in ADHD Plus Oppositional Symptoms — Completed
• Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD) — Completed
• Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder — Completed
• Tolerability and Efficacy of AM and PM Once Daily Dosing With Extended-release Guanfacine Hydrochloride in Children 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD) (The ADHD Tempo Study) — Completed
• Long Term Safety Study of Tanezumab in Chronic Low Back Pain — Stopped early
• Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD) — Stopped early
• Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Velpatasvir in Participants With Chronic HCV Infection — Completed
• Long-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain. Includes a 24-week Extension Period. — Completed
• Efficacy and Safety of Hydrocodone Bitartrate (HYD) in Subjects With Moderate to Severe Chronic Low Back Pain — Completed
• An Inpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Treatment Of Acute Exacerbation Of Schizophrenia — Completed
• Single-Dose And Multiple-Dose Safety And Tolerability Study Of PF-04856883 In Type 2 Diabetic Adult Females — Completed
• Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders — Completed
• Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects — Completed
• Lurasidone Pediatric Pharmacokinetics Study — Completed
• Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain — Completed
• Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on) — Completed
• Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy) — Completed
• Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD) — Completed
• A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B — Completed
• Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder. — Completed
• Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease — Completed
• A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis C — Completed
• Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression — Completed
• Dose-Finding Study to Evaluate the Efficacy and Safety of Modafinil as Treatment for Adults With ADHD — Completed
• Efficacy and Safety of DOV 21,947 in the Treatment of Major Depressive Disorder — Stopped early